Tcg Crossover Management, LLC Alpine Immune Sciences, Inc. Transaction History

Tcg Crossover Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.45 - $7.35 $8,175 - $11,025	-1,500 Reduced 0.59%	253,069 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$6.89 - $9.39 $2.23 Million - $3.04 Million	-323,691 Reduced 55.98%	254,569 $1.83 Million
Q2 2022 Aug 15, 2022	SELL	$6.71 - $9.52 $3.06 Million - $4.34 Million	-455,962 Reduced 44.09%	578,260 $4.92 Million
Q1 2022 May 16, 2022	SELL	$6.41 - $13.89 $871,695 - $1.89 Million	-135,990 Reduced 11.62%	1,034,222 $9.28 Million
Q4 2021 Feb 18, 2022	BUY	$10.41 - $13.95 $12.2 Million - $16.3 Million	1,170,212 New	1,170,212 $16.2 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tcg Crossover Management, LLC with notifications on news.